Is Innovent Biologics Inc stock a buy?

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Innovent Biologics Inc 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD24.45, you would have made a profit of HKD18.70 per share or 76.48%

Yes, the average daily trading liquidity for Innovent Biologics Inc is HKD5.85 million. You should therefore be able to get in and out of your positions relatively fast.

Innovent Biologics Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.04, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Innovent Biologics Inc to be high [0.75 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.